|Bodisen Biotech, Inc. (ˇ°Bodisenˇ± or the ˇ°Companyˇ±) AGM Notice and Proxy Statement
Further to the announcement of November 17 2006, confirming that the annual shareholders meeting would be held on 27 December 2006, the Company confirms that it has yesterday sent formal notice of the meeting to shareholders (the ˇ°Noticeˇ±), together with the proxy statement, which is furnished in connection with the solicitation of proxies by the Board of Directors of Bodisen for use at that Annual General Meeting.
As some shareholders hold their interest in the Company through a Crest Depositary Interest representing the underlying common stock (ˇ°CDIˇ±), the Company will arrange for this documentation to be forwarded to the CDI holders, but the full text of the Notice and the accompanying proxy statement are set out below.
Charles Stanley Securities (Nominated Adviser)
Rick Thompson / Freddy Crossley 0207 149 6000